Provectus PV-10 Phase 2 trial data on metastatic melanoma to be presented at two conf

[News]

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that data from its Phase 2 PV-10 metastatic melanoma study will be presented at two upcoming melanoma conferences.

More... (http://www.news-medical.net/news/20110616/Provectus-PV-10-Phase-2-trial-data-on-metastatic-melanoma-to-be-presented-at-two-conferences.aspx)